THE UTILITY OF TISSUE TRANSGLUTAMINASE AS A MARKER OF APOPTOSIS DURING TREATMENT AND PROGRESSION OF PROSTATE CANCER

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

1992 • 9,540 citations

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

1984 • 4,180 citations

Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

1941 • 3,235 citations

Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

1972 • 1,030 citations

Carcinoma of the Prostate

1991 • 755 citations

Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration

1989 • 266 citations

Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY

1996 • 207 citations

Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors.

1995 • 158 citations

Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.

1996 • 146 citations

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer

1996 • 142 citations

Evidence for atrophy and apoptosis in the prostates of men given finasteride.

1996 • 140 citations

?Tissue? transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation

1991 • 138 citations

Ki-67 Expression is a Prognostic Marker of Prostate Cancer Recurrence after Radical Prostatectomy

1996 • 132 citations

Expression of cell cycle-regulated proteins in prostate cancer.

1996 • 131 citations

Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.

1998 • 117 citations

Evidence for atrophy and apoptosis in the prostates of men given finasteride

1996 • 62 citations

Application of the Monoclonal Antibody Ki-67 on Prostate Biopsies to Assess the Proliferative Cell Fraction of Human Prostatic Carcinoma

1991 • 60 citations

Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer

1997 • 52 citations

Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.

1996 • 40 citations

Apoptosis in Prostatic Adenocarcinoma following Complete Androgen Ablation

1998 • 37 citations

Detection of apoptosis by the TUNEL technique in clinically localised prostatic cancer before and after combined endocrine therapy.

1997 • 29 citations

Prognostic markers in clinically localized prostate cancer.

1998 • 25 citations

Adjunctive Value of Cell Proliferation but Not of Apoptosis to Interpret Pathologic Effects on Prostatic Cancer after Neoadjuvant Endocrine Therapy

1998 • 3 citations